Pharmacokinetics and Safety of Boosted Elvitegravir in Subjects with Hepatic Impairment

Authors

Keywords

Journal

Volume 58, Issue 5, Pages 2564-2569

Publisher

American Society for Microbiology

Online

2014-02-19

DOI

10.1128/aac.02180-13

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started